Breast Cancer Imaging Using the Near-Infrared Fluorescent Agent, CLR1502
Positive margins after breast conservation surgery represent a significant problem in the treatment of breast cancer. The near-infrared fluorescence agent CLR1502 (Cellectar Biosciences, Madison, WI) was studied in a preclinical breast cancer model to determine imaging properties and ability to dete...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2015-01-01
|
Series: | Molecular Imaging |
Online Access: | https://doi.org/10.2310/7290.2014.00040 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|